When Japanese cosmetics company Kanebo decided to recall their whitening products last June 28 due to complaints of skin blotching, they still continued shipping the items because they wanted to avoid “confusing” their customers. The recall was announced almost a week later on July 6 and this might have caused an increase in the number of those who were affected.
An official from the company said that even as they continued to deliver the whitening products to customers, they were already setting in place call centers to take on the expected complaints and inquiries as well as “making other preparations” to ensure that there will be no confusion and backlash because of the recall. As of August 25, 8,678 customers domestically have been confirmed to experience blotching due to the use of Kanebo products, including the popular “Blanchir Superior” line of creams. 65 people overseas have also reported uneven colouring because of the cosmetics.
Kanebo recalled 54 of their products, including the 4.75 million units that were already on the shelves of retail stores. The cause of the blotching is believed the be 4HPB, a synthetic version of a natural compound that was developed exclusively by the company and which received approval from the Ministry of Health, Labour and Welfare after passing extensive safety tests in accordance to the Pharmaceutical Affairs Act. Kanebo has said they will be paying for the medical costs of those who have been affected, including those who continued to experience the blotching long after they stopped using the products. Aside from Japan, the recall also involves Britain, Taiwan, Hong Kong, South Korea, Thailand, Singapore, Malaysia, Indonesia, Myanmar, the Philippines and Vietnam.
[ via Yahoo ]
Comments Off on JDP Startup Corner: Pros & Cons of Working with a Partner in Japan